12:00 AM
 | 
Jul 15, 2013
 |  BC Week In Review  |  Company News  |  Sales & Marketing

Chiesi, uniQure sales and marketing update

uniQure granted Chiesi exclusive rights to commercialize Glybera alipogene tiparvovec and co-develop and commercialize AMT-060 in Europe, Brazil, Mexico, Pakistan, Turkey and the Commonwealth of Independent States (CIS). Chiesi also received commercialization rights to Glybera in China....

Read the full 183 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >